Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris
NCT ID: NCT03411733
Last Updated: 2018-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2017-03-01
2018-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
NCT06179056
Clinico-demographic Features of Patients With Acne Vulgaris
NCT05061615
Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate
NCT07062081
A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions
NCT01160757
the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris
NCT00419848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients were subjected to complete history, general and skin examination Acne vlugaris Patients were classified into mild, moderate and severe according to the classification of American Academy of dermatology for acne vulgaris.
Detection of H. pylori infection:
Blood and stool samples were taken from each participant and was directly transferred to laboratory for detection of H. Pylori antigen and antibody.
An enzyme-linked immune sorbent assay (ELISA) was used for quantitative assessment of IgG antibodies against H.Pylori in human serum.
A monoclonal antibodies based enzyme-linked immunosorbent assay was used to detect H.Pylori specific antigen in stool samples.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
acne vlugaris group
Included recruited patients with acne vulgaris Intervention: Blood and stool samples collection
Blood and stool samples collection
Collection of blood and stool samples from each participants for H.pylori antigen/ antibody detection
Control group
Included healthy participants Intervention: Blood and stool samples collection
Blood and stool samples collection
Collection of blood and stool samples from each participants for H.pylori antigen/ antibody detection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood and stool samples collection
Collection of blood and stool samples from each participants for H.pylori antigen/ antibody detection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy volunteers (control)
Exclusion Criteria
12 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Ali
Resident physician, Department of Dermatology, Sohag Educational Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ramadan Saleh, MD
Role: STUDY_DIRECTOR
Sohag Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology outpatient clinic, Sohag University Hospital
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPAV001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.